Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Walter A. Shaw, Ph.D, Avanti Polar Lipids, Inc.
ClinicalTrials.gov Identifier:
NCT00406536
First received: November 29, 2006
Last updated: January 11, 2013
Last verified: January 2013